Study: Heart damage after chemo linked to stress in cardiac cells
Blocking a protein in the heart that is produced under stressful conditions could be a strategy to prevent cardiac damage that results from chemotherapy, a new study suggests.
Cardiology
May 21, 2012 |
not rated yet |
1
|
ASCO: For chemo's nausea, olanzapine beats metoclopramide
(HealthDay) -- For patients receiving highly emetogenic chemotherapy who experience breakthrough chemotherapy-induced nausea and vomiting, treatment with olanzapine (Zyprexa) is significantly better than treatment ...
Cancer
May 17, 2012 |
not rated yet |
0
Many primary care docs don't know long-term effects of chemo: survey
(HealthDay) -- Many primary care doctors don't know the long-term side effects of the chemotherapy treatments that cancer survivors under their care may have been given, a new survey found.
Cancer
May 17, 2012 |
5 / 5 (2) |
1
Targeted therapy with pazopanib prolongs progression-free survival in advanced soft-tissue sarcoma
For patients with metastatic soft-tissue sarcoma whose disease has progressed following standard chemotherapy, treatment with pazopanib (a drug that targets the growth of new cancer-related blood vessels) nearly tripled progression-free ...
Cancer
May 15, 2012 |
not rated yet |
0
Improved treatment for head & neck cancers could soon be on its way, say UK researchers
Engineers and scientists at the University of Glasgow are developing a new method of treating head and neck cancers they believe will make therapy more targeted and effective.
Cancer
May 07, 2012 |
not rated yet |
0
Component of pizza seasoning herb oregano kills prostate cancer cells
Oregano, the common pizza and pasta seasoning herb, has long been known to possess a variety of beneficial health effects, but a new study by researchers at Long Island University (LIU) indicates that an ingredient of this ...
Cancer
Apr 24, 2012 |
not rated yet |
0
Study examines drug regimen for the treatment of non-small cell lung cancer among older patients
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients ...
Cancer
Apr 17, 2012 |
not rated yet |
0
New radiation therapy reduces treatment of gynecologic cancers from 5 weeks to 3 days
About 71,500 women in the United States are diagnosed with a gynecologic cancer every year, according to the Centers for Disease Control. Researchers from University Hospitals Case Medical Center have developed ...
Cancer
Apr 17, 2012 |
not rated yet |
0
Breast cancer patients suffer treatment-related side effects long after completing care
More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at ...
Cancer
Apr 09, 2012 |
not rated yet |
0
|
Less intense chemotherapy more effective and less toxic for patients with advanced Hodgkin's lymphoma
A study published Online First by The Lancet has found that patients with advanced Hodgkin's lymphoma (a cancer affecting lymph tissue) can be treated more effectively with lower doses of chemotherapy. The study is by Dr ...
Cancer
Apr 03, 2012 |
5 / 5 (1) |
0
Cancer stem cell vaccine in development shows antitumor effect
Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Associ ...
Cancer
Apr 02, 2012 |
4.5 / 5 (4) |
0
Some breast cancer tumors may be resistant to a common chemotherapy treatment
Some breast cancer tumours may be resistant to a common chemotherapy treatment, suggests recent medical research at the University of Alberta.
Cancer
Mar 27, 2012 |
not rated yet |
0
|
Cryoablation therapy spot-freezes breast cancer tumors
Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation. The cancer treatment could potentially ...
Cancer
Mar 26, 2012 |
not rated yet |
0
Scientists reprogram cancer cells with low doses of epigenetic drugs
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) ...
Cancer
Mar 22, 2012 |
5 / 5 (1) |
0
|
New genomic test spares patients chemotherapy with no adverse effect on survival
Testing a breast cancer tumour for its genomic signature can help identify which patients will need adjuvant systemic therapy (additional chemotherapy) after surgery, and spare its use in those for whom it is not necessary, ...
Cancer
Mar 22, 2012 |
not rated yet |
0
